AI-powered rare disease intelligence
Transforming genomic, clinical, and population data into insights that improve outcomes, advance equity, and reduce the cost and capacity strain of late-stage disease.
With advanced AI and global health data, we can
SEE
the hidden drivers of late-stage progression that health systems miss
FORECAST
recurrence, progression, and high-burden events before they overwhelm patients and services
DELIVER
actionable insights to health systems, payers, and clinicians — without disrupting workflows
CHANGE
the future of rare disease care by closing equity gaps, improving survival, and reducing avoidable late-stage costs
Our Technology
AnnieGuard is building a rare disease intelligence platform designed to detect aggressive biology earlier, improve survival, and relieve system burden.
Thousands
of de-identified health records analyzed across genomic, clinical, and population data streams
​​
7-day turnaround
from secure dataset to actionable, population-level insights
​​
Improved survival
through earlier detection of hidden progression risk
​​
System relief
by reducing avoidable late-stage cases that drive the highest burden of oncology care
​
Validated evidence
aligned with NHS early detection goals and U.S. value-based care models
​
Seamless deployment
no workflow disruption, compliant with HIPAA, GDPR, and NHS DSPT
​
Scalable platform
sarcoma first, with expansion into other rare diseases
This is AI-powered rare disease intelligence.
This is the future of proactive, equitable healthcare.
71-75 Shelton Street
Covent Garden, London
United Kingdom, WC2H 9JQ
​
+44 7520 643580
Copyright © 2025 AnnieGuard Corporation, trading as AnnieGuard Ltd. All rights reserved. Privacy Policy
